← Evidence map

ReviewMicrobial drug resistance (Larchmont, N.Y.)2021

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.

Guillaume Hache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33729874